Individual radiosensitivity in a breast cancer collective is changed with the patients’ age

1. Huber R, Braselmann H, Geinitz H, Jaehnert J, Baumgartner A, Thamm R, et al. Chromosomal radiosensitivity and acute radiation side effects after radiotherapy in tumour patients--a follow-up study. Radiat Oncol 2011; 6: 32.10.1186/1748-717X-6-32Search in Google Scholar

2. Dikomey E, Borgmann K, Peacock J, Jung H. Why recent studies relating normal tissue response to individual radiosensitivity might have failed and how new studies should be performed. Int J Radiat Oncol Biol Phys 2003; 56: 1194-200.10.1016/S0360-3016(03)00188-3Search in Google Scholar

3. Zschenker O, Raabe A, Boeckelmann IK, Borstelmann S, Szymczak S, Wellek S, et al. Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity. Radiother Oncol 2010; 97: 26-32.10.1016/j.radonc.2010.01.01620170971Search in Google Scholar

4. Lopez E, Guerrero R, Nunez MI, del Moral R, Villalobos M, Martinez-Galan J, et al. Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes. Breast Cancer Res 2005; 7: R690-8.10.1186/bcr1277124213516168114Search in Google Scholar

5. Ambrosone CB, Tian C, Ahn J, Kropp S, Helmbold I, von Fournier D, et al. Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: a case-series study. Breast Cancer Res 2006; 8: R40.10.1186/bcr1526177946916848913Search in Google Scholar

6. Borgmann K, Haeberle D, Doerk T, Busjahn A, Stephan G, Dikomey E. Genetic determination of chromosomal radiosensitivities in G0- and G2- phase human lymphocytes. Radiother Oncol 2007; 83: 196-202.10.1016/j.radonc.2007.04.01017499867Search in Google Scholar

7. Distel LV, Neubauer S, Keller U, Sprung CN, Sauer R, Grabenbauer GG. Individual differences in chromosomal aberrations after in vitro irradiation of cells from healthy individuals, cancer and cancer susceptibility syndrome patients. Radiother Oncol 2006; 81: 257-63.10.1016/j.radonc.2006.10.01217113667Search in Google Scholar

8. Pantelias GE, Terzoudi GI. A standardized G2-assay for the prediction of individual radiosensitivity. Radiother Oncol 2011; 101: 28-34.10.1016/j.radonc.2011.09.02122014898Search in Google Scholar

9. Scott D. Chromosomal radiosensitivity, cancer predisposition and response to radiotherapy. Strahlenther Onkol 2000; 176: 229-34.10.1007/s00066005000510847120Search in Google Scholar

10. Scott D. Chromosomal radiosensitivity and low penetrance predisposition to cancer. Cytogenet Genome Res 2004; 104: 365-70.10.1159/00007751715162066Search in Google Scholar

11. Jung H, Beck-Bornholdt HP, Svoboda V, Alberti W, Herrmann T. Quantification of late complications after radiation therapy. Radiother Oncol 2001; 61: 233-46.10.1016/S0167-8140(01)00457-1Search in Google Scholar

12. Neubauer S, Dunst J, Gebhart E. The impact of complex chromosomal rearrangements on the detection of radiosensitivity in cancer patients. Radiother Oncol 1997; 43: 189-95.10.1016/S0167-8140(97)01932-4Search in Google Scholar

13. Neubauer S, Gebhart E, Schmitt G, Birkenhake S, Dunst J. Is chromosome in situ suppression (CISS) hybridization suited as a predictive test for intrinsic radiosensitivity in cancer patients? Int J Oncol 1996; 8: 707-12.Search in Google Scholar

14. Keller U, Grabenbauer G, Kuechler A, Sprung C, Müller E, Sauer R, et al. Cytogenetic instability in young patients with multiple primary cancers. Cancer Genet Cytogenet 2005; 157: 25-32.10.1016/j.cancergencyto.2004.05.01815676143Search in Google Scholar

15. Keller U, Grabenbauer G, Kuechler A, Sauer R, Distel L. Radiation sensitivity testing by FISH: how many metaphases have to be analysed? Int J Radiat Biol 2004; 80: 615-20.Search in Google Scholar

16. Baeyens A, Van Den Broecke R, Makar A, Thierens H, De Ridder L, Vral A. Chromosomal radiosensitivity in breast cancer patients: influence of age of onset of the disease. Oncol Rep 2005; 13: 347-53. Search in Google Scholar

17. Vineis P. Individual susceptibility to carcinogens. Oncogene 2004; 23: 6477-83.10.1038/sj.onc.120789715322518Search in Google Scholar

18. Oblak I, Petric P, Anderluh F, Velenik V, Fras PA. Long term outcome after combined modality treatment for anal cancer. Radiol Oncol 2012; 46: 145-52.10.2478/v10019-012-0022-2347293123077451Search in Google Scholar

19. Trost N, Juvan P, Sersa G, Debeljak N. Contrasting effect of recombinant human erythropoietin on breast cancer cell response to cisplatin induced cytotoxicity. Radiol Oncol 2012; 46: 213-25.10.2478/v10019-012-0037-8347295223077460Search in Google Scholar

20. Ott OJ, Hildebrandt G, Potter R, Hammer J, Lotter M, Resch A, et al. Accelerated partial breast irradiation with multi-catheter brachytherapy: Local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial. Radiother Oncol 2007; 82: 281-6.10.1016/j.radonc.2006.08.02817126940Search in Google Scholar

21. Mladinic M, Kopjar N, Milic M, Dasovic AB, Huzak M, Zeljezic D. Genomic instability in a healthy elderly population: a pilot study of possible cytogenetic markers related to ageing. Mutagenesis 2010; 25: 455-62.10.1093/mutage/geq02720504867Search in Google Scholar

22. Melchor L, Benitez J. The complex genetic landscape of familial breast cancer. Hum Genet 2013; 132: 845-63.10.1007/s00439-013-1299-y23552954Search in Google Scholar

23. Braithwaite D, Moore DH, Satariano WA, Kwan ML, Hiatt RA, Kroenke C, et al. Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomarkers Prev 2012; 21: 1115-25.10.1158/1055-9965.EPI-11-1228347087322573797Search in Google Scholar

24. Demoor-Goldschmidt C, Supiot S, Mahe MA. Breast cancer after radiotherapy: Risk factors and suggestion for breast delineation as an organ at risk in the prepuberal girl. Cancer Radiother 2012; 16: 140-51.10.1016/j.canrad.2011.10.01422342367Search in Google Scholar

25. Huang YS, Lee CC, Chang TS, Ho HC, Su YC, Hung SK, et al. Increased risk of stroke in young head and neck cancer patients treated with radiotherapy or chemotherapy. Oral Oncol 2011; 47: 1092-7. 10.1016/j.oraloncology.2011.07.02421852184Search in Google Scholar